The Journal of Neuroscience, December 26, 2007, 27(52):14448-14458; doi:10.1523/JNEUROSCI.2279-07.2007
Previous Article | Next Article 
Cellular/Molecular
A TAT–DEF–Elk-1 Peptide Regulates the Cytonuclear Trafficking of Elk-1 and Controls Cytoskeleton Dynamics
Jérémie Lavaur,1,3
Frédéric Bernard,2,3
Pierre Trifilieff,1,3,4,5
Vincent Pascoli,1,3
Vincent Kappes,1,3
Christiane Pagès,1,3
Peter Vanhoutte,1,3 and
Jocelyne Caboche1,3
1Signalisation Neuronale et Régulations Géniques and 2Développement Neuronal, Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 7102, 75005 Paris, France, 3Université Pierre et Marie Curie-Paris 6, 75005 Paris, France, 4CNRS, UMR 5106, 33405 Talence, France, and 5Université Bordeaux I, 33405 Talence, France
Correspondence should be addressed to Dr. Jocelyne Caboche, Université Pierre et Marie Curie-Paris 6, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7102, 9 quai Saint Bernard, 75005 Paris, France. Email: jocelyne.caboche{at}snv.jussieu.fr
The transcription factor Elk-1 plays a key role in cell differentiation, proliferation and apoptosis. This role is thought to arise from its phosphorylation by activated extracellular signal-regulated kinases (ERKs), a critical posttranslational event for the transcriptional activity of the ternary complex composed of Elk-1 and a dimer of serum response factor (SRF) at the serum response element (SRE) regulatory site of transcription. In addition to its nuclear localization, Elk-1 is found in the dendrites and soma of neuronal cells and recent evidence implicate a cytoplasmic proapoptotic function of Elk-1, via its association with the mitochondrial permeability transition pore complex. Thus, the nuclear versus cytoplasmic localization of Elk-1 seems to be crucial for its biological function. In this study we show that the excitatory neurotransmitter, glutamate, induces an ERK-dependent Elk-1 activation and nuclear relocalization. We demonstrate that Elk-1 phosphorylation on Ser383/389 has a dual function and triggers both Elk-1 nuclear translocation and SRE-dependent gene expression. Mutating these sites into inactive residues or using a synthetic penetrating peptide (TAT–DEF–Elk-1), which specifically interferes with the DEF docking domain of Elk-1, prevents Elk-1 nuclear translocation without interfering with ERK nor MSK1 (mitogen- and stress-activated protein kinase 1), a CREB kinase downstream from ERK- activation. This results in a differential regulation of glutamate-induced IEG regulation when compared with classical inhibitors of the ERK pathway. Using the TAT–DEF–Elk-1 peptide or the dominant-negative version of Elk-1, we show that Elk-1 phosphorylation controls dendritic elongation, SRF and Actin expression levels as well as cytoskeleton dynamics.
Key words: extracellular signal-regulated kinase (ERK); Elk-1; Elk-1 inhibitor; trafficking; gene regulations; neuronal differentiation; TAT–DEF–Elk-1 peptide
Received May 18, 2007;
revised Oct. 29, 2007;
accepted Nov. 6, 2007.
Correspondence should be addressed to Dr. Jocelyne Caboche, Université Pierre et Marie Curie-Paris 6, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7102, 9 quai Saint Bernard, 75005 Paris, France. Email: jocelyne.caboche{at}snv.jussieu.fr